Variables | All patients (n = 568) | Severe AKI | p value | |
---|---|---|---|---|
No (n = 294) | Yes (n = 274) | |||
Male, n (%) | 404 (71) | 219 (74) | 185 (67) | 0.04 |
Age, years | 59 (49–71) | 56 (47–69) | 62 (50–72) | < 0.01 |
BMI, kg/m2 | 25 (23–28) | 25 (22–27) | 26 (23–29) | 0.16 |
Hypertension, n (%) | 219 (39) | 108 (37) | 111 (40) | 0.89 |
Diabetes, n (%) | 89 (16) | 42 (14) | 47 (17) | 0.62 |
Witnessed CA, n (%) | 491 (86) | 262 (89) | 229 (84) | 0.05 |
Bystander CPR, n (%) | 309 (54) | 169 (57) | 140 (51) | 0.05 |
VF/VT, n (%) | 324 (57) | 188 (64) | 136 (50) | < 0.01 |
Epinephrine use during CPR, mg | 2.8 ± 3.6 | 2.2 ± 3.2 | 3.5 ± 3.8 | < 0.01 |
Time from collapse to CPR, min | 4.9 ± 5.5 | 4.2 ± 4.4 | 5.8 ± 6.4 | < 0.01 |
Time from CPR to ROSC, min | 17.8 ± 11.9 | 15.2 ± 10.0 | 20.6 ± 13.1 | < 0.01 |
Iodinated contrast, n (%) | 421 (74) | 219 (74) | 202 (74) | 0.90 |
Coronary angiogram, n (%) | 408 (72) | 213 (72) | 195 (71) | 0.28 |
Admission creatinine level, μmol/L | 109 ± 53 | 94 ± 37 | 125 ± 63 | < 0.01 |
Admission lactate level, mmol/L | 5.0 ± 3.6 | 3.9 ± 3.8 | 6.3 ± 4.0 | < 0.01 |
Diuresis within the first 24 h, mL/kg/h | 0.9 ± 0.8 | 1.7 ± 0.6 | 0.5 ± 0.6 | < 0.01 |
Patients under norepinephrine, n (%) | ||||
At 6 h | 175 (31) | 76 (26) | 99 (36) | < 0.01 |
At 12 h | 144 (25) | 67 (23) | 77 (28) | 0.16 |
Norepinephrine dosage, μg/kg/min | ||||
Within first 6 h | 0.12 ± 0.36 | 0.07 ± 0.21 | 0.18 ± 0.47 | < 0.01 |
Within first 12 h | 0.11 ± 0.32 | 0.07 ± 0.23 | 0.15 ± 0.39 | < 0.01 |
Day-30 mortality, n (%) | 328 (58) | 135 (46) | 193 (70) | < 0.01 |